ATXI - Avenue Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development17,6967,8011,3804,364.727
Selling General and Administrative4,1203,620997918.545
Non Recurring----
Total Operating Expenses21,81611,4212,3775,283.272
Operating Income or Loss-21,816-11,421-2,377-5,283.272
Income from Continuing Operations
Total Other Income/Expenses Net268-837-800-417.818
Earnings Before Interest and Taxes-21,816-11,421-2,377-5,283.272
Interest Expense--375-612-417.818
Income Before Tax-21,548-12,258-3,177-5,701.09
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-21,548-12,258-3,177-5,701.09
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,548-12,258-3,177-5,701.09
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,548-12,258-3,177-5,701.09